Internal Medicine, Hematology & Oncology · Ocala, FL
NPI
1285644708
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
321 SE 29th Pl, Ste 102
Ocala, FL, 34471
Phone (352) 622-9631
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
106,793 services
Medicare patients, 2024
615
Average age 76
Drug cost, 2024
$2.3M
2,194 prescriptions
Company payments, 2025
$3,353
From 45 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel A Patterson was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 14,280 times for 14 patients. In total Daniel A Patterson billed 106,793 services in 83 codes, and Medicare paid $1.5M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-10-04.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 14,280 | 14 | $0.28 | $3,957 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 7,420 | 25 | $5.66 | $42K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 6,772 | 92 | $0.09 | $607 |
| J0897 Injection, denosumab, 1 mg | Office | 6,720 | 39 | $20.56 | $138K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 4,088 | 43 | $0.07 | $301 |
| 36415 Venipuncture Blood Collection | Office | 2,079 | 385 | $8.65 | $18K |
| 85025 Blood Count | Office | 2,033 | 381 | $7.59 | $15K |
| J1750 Injection, iron dextran, 50 mg | Office | 1,360 | 48 | $13.67 | $19K |
| 99214 Office E&M - Established | Office | 1,069 | 325 | $99.11 | $106K |
| 96372 Injection Administration | Office | 712 | 107 | $10.94 | $7,788 |
| 96375 Injection Administration | Office | 688 | 92 | $11.87 | $8,164 |
| 99233 Hospital E&M - Subsequent | Facility | 677 | 200 | $97.89 | $66K |
| 80053 Clinical Chemistry | Office | 588 | 190 | $10.35 | $6,086 |
| 96367 Intravenous Infusion, Hydration | Office | 490 | 80 | $21.34 | $10K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 455 | 64 | $0.95 | $432 |
By year: 2022 $1.4M for 110,083 services; 2023 $1.4M for 152,938 services; 2024 $1.5M for 106,793 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,079 | 385 | $8.65 | $18K |
| 85025 Blood Count | 2,033 | 381 | $7.59 | $15K |
| 80053 Clinical Chemistry | 588 | 190 | $10.35 | $6,086 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel A Patterson prescribed most often to Medicare patients was Eliquis (Apixaban), with 227 prescriptions and refills. In total Daniel A Patterson wrote 2,194 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 227 | 306 | 45 | $174K |
| Lorazepam Generic | 80 | 84 | 58 | $228 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 75 | 75 | 35 | $1,663 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 73 | 73 | 17 | $3,881 |
| Hydroxyurea Generic | 71 | 165 | 21 | $2,056 |
| Oxycodone Hcl Generic | 67 | 68 | 25 | $1,249 |
| Anastrozole Generic | 65 | 165 | 18 | $994 |
| Levofloxacin Generic | 65 | 65 | 31 | $594 |
| Alprazolam Generic | 57 | 57 | Under 11 | $483 |
| Prednisone Generic | 55 | 89 | 22 | $240 |
| Tramadol Hcl Generic | 51 | 56 | 21 | $587 |
| Folic Acid Generic | 51 | 84 | 15 | $250 |
| Gabapentin Generic | 44 | 78 | 16 | $754 |
| Fluconazole Generic | 43 | 47 | 26 | $972 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 38 | 38 | 25 | $490 |
Brand drugs: - claims; generic drugs: 1,767 claims; opioid claims: 324.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel A Patterson $3,353 ($3,353 in general payments such as food, travel and fees) from 45 companies. The largest payer was Novartis Pharmaceuticals Corporation with $476.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 9 | $476 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $279 |
| Jazz Pharmaceuticals Inc. JAZZ | 3 | $217 |
| GlaxoSmithKline, LLC. GSK | 8 | $148 |
| Tempus AI, Inc TEM | 5 | $139 |
| Caris MPI, Inc. | 3 | $138 |
| Pfizer Inc. PFE | 5 | $122 |
| Celgene Corporation BMY | 5 | $118 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $116 |
| BeOne Medicines USA, Inc. ONC | 4 | $108 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.